Make it your homepage |   E-mail: Subscribe Unsubscribe

‘Big Data’ Can Be Hard to Harness


Tuesday, May 22, 2012
News Making Money

beautytop.jpg

ASP Offers Education and Solutions for Preventing Healthcare-Associated Infections at 59th Annual

The FINANCIAL -- As one of a leading provider of education and technology for combating healthcare-associated infections over the past 25 years, ASP will deliver an educational workshop on infection prevention at the 59th Annual Association of periOperative Registered Nurses Congress taking place March 24-29, 2012 in New Orleans.

Read more...
Indian table grapes from cooperation between Bayer CropScience and UNIVEG shipped to Europe

The FINANCIAL -- A global food chain partnership project between Bayer CropScience and UNIVEG Group has borne new fruit, with the successful first shipment of high-quality grapes from India to Europe.

Read more...
Investigational Study May Help Researchers Develop Test That Predicts Risk of Imminent Heart Attacks

The FINANCIAL --  Veridex, LLC  announced the publication of a new, investigational study published this week in Science Translational Medicine that lays the foundation for research that may potentially result in a blood test to determine imminent risk of heart attack within high-risk populations.

Read more...
GSK confirms significant investments in UK manufacturing

The FINANCIAL -- GSK confirmed that it will invest more than £500m in the UK across its manufacturing sites to increase production of key active ingredients for its pharmaceutical products and vaccines. 

Read more...
GSK announces positive vote from FDA panel for pazopanib in certain advanced soft tissue sarcomas

The FINANCIAL -- GlaxoSmithKline announced today that the Oncologic Drugs Advisory Committee to the US FDA voted 11 to 2 that evidence from clinical studies support a favourable benefit – risk assessment for use of Votrient in treating patients with advanced soft tissue sarcoma who have received prior chemotherapy, noting that those with gastrointestinal stromal tumours and adipocytic sarcomas were not included in the Phase III trial.  The ODAC reviewed findings from one Phase III clinical study and one Phase II study.

Read more...
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Results 91 - 105 of 419

This text is replaced by the Flash movie.
This text is replaced by the Flash movie.












Developed by Aleksandre Chiabrishvili

Design built by Creo Group